A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Rising prevalence of respiratory diseases 3.2.1.2 Growing government approvals and funding 3.2.1.3 Expanding elderly demographic 3.2.1.4 Growing advancement in the drug delivery system 3.2.2 Industry pitfalls & challenges 3.2.2.1 Availability of alternative therapeutic options 3.2.2.2 Side effects and safety concerns 3.3 Growth potential analysis 3.4 Pipeline analysis 3.5 Regulatory landscape 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Company matrix analysis 4.4 Competitive analysis of major market players 4.5 Competitive positioning matrix 4.6 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Injection 5.3 Tablet 5.4 Solution Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Generics 6.3 Branded Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Asthma 7.3 Emphysema 7.4 Chronic obstructive pulmonary disease (COPD) 7.5 Other applications Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Retail pharmacies 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Rest of Latin America 9.6 Middle East and Africa 9.6.1 Saudi Arabia 9.6.2 South Africa 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 AdvaCare Pharma 10.2 Amneal Pharmaceuticals LLC 10.3 AstraZeneca AB 10.4 Cipla 10.5 Cooper S.A. 10.6 GSK plc 10.7 Glenmark Pharmaceuticals Ltd. 10.8 Inopha International Co, Limited 10.9 Johnson & Johnson Pvt. Ltd. 10.10 Lupin 10.11 Pfizer Inc. 10.12 S.A.L.F. S.p.A. Laboratorio Farmacologico 10.13 Teva Pharmaceuticals Industries Ltd.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook